Financial burden of cancer clinical trial participation and the impact of a cancer care equity program

Oncologist

Volumn 21, Issue 4, 2016, Pages 467-474

  Nipp, Ryan D ^a   Lee, Hang ^a   Powell, Elizabeth ^a   Birrer, Nicole E ^a   Poles, Emily ^a   Finkelstein, Daniel ^a   Winkfield, Karen ^a   Percac Lima, Sanja ^a   Chabner, Bruce ^a   Moy, Beverly ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

Clinical trial; Cost of illness; Financial support; Health care costs; Quality of life

Indexed keywords

ADULT; ARTICLE; CANCER RESEARCH; CONTROLLED STUDY; FINANCE; GENDER; HEALTH CARE COST; HEALTH EQUITY; HUMAN; INSURANCE; MARRIAGE; PRIORITY JOURNAL; TRAVEL; AGED; CLINICAL TRIAL; ECONOMICS; FEMALE; HEALTH CARE DELIVERY; MALE; MIDDLE AGED; NEOPLASMS; PATHOLOGY; PATIENT PARTICIPATION; PATIENT SELECTION; POVERTY; QUESTIONNAIRE;

AGED; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT PARTICIPATION; PATIENT SELECTION; POVERTY; SURVEYS AND QUESTIONNAIRES;

EID: 84963865381     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2015-0481     Document Type: Article

References (54)

1. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: Race-, sex-, and age based disparities. JAMA 2004;291:2720–2726.
2. Scoggins JF, Ramsey SD. A national cancer clinical trials system for the 21st century: Reinvigorating the NCI Cooperative Group Program. J Natl Cancer Inst 2010;102:1371.
3. Nass SJ, Moses HL, Mendelsohn J, eds. A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. Washington, DC: National Academics Press, 2010.
4. Fouad MN, Lee JY, Catalano PJ et al. Enrollment of patients with lung and colorectal cancers onto clinical trials. J Oncol Pract 2013;9:e40–e47.
5. Lara PN Jr., Higdon R, Lim N et al. Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment. J Clin Oncol 2001;19:1728–1733.
6. Somkin CP, Altschuler A, Ackerson L et al. Organizational barriers to physician participation in cancer clinical trials. AmJ Manag Care 2005;11:413–421.
7. Fu S, McQuinn L, Naing A et al. Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit. The Oncologist 2013;18:1315–1320.
8. Young RC. Cancer clinical trials–a chronic but curable crisis. N Engl J Med 2010;363:306–309.
9. Umutyan A, Chiechi C, Beckett LA, et al. Overcoming barriers to cancer clinical trial accrual: Impact of amass media campaign. Cancer 2008;112:212–219.
10. Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US Food and Drug Administration. J Clin Oncol 2004;22:4626–4631.
11. Townsley CA, Selby R, Siu LL. Systematic review of barriersto therecruitment ofolderpatientswith cancer onto clinical trials. J Clin Oncol 2005;23:3112–3124.
12. Unger JM, Gralow JR, Albain KS et al. Patient income level and cancer clinical trial participation: A prospective survey study 2016;2:137–139.
13. Sateren WB, Trimble EL, Abrams J et al. How sociodemographics, presenceofoncologyspecialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002;20:2109–2117.
14. Baquet CR, Ellison GL, Mishra SI. Analysis of Maryland cancer patient participation in National Cancer Institute-supported cancer treatment clinical trials. J Clin Oncol 2008;26:3380–3386.
15. Ford JG, Howerton MW, Lai GY et al. Barriers to recruitingunderrepresentedpopulationstocancerclinical trials: A systematic review. Cancer 2008;112:228–242.
16. Gross CP, Steiner CA, Bass EB et al. Relation between prepublication release of clinical trial results and the practice of carotid endarterectomy. JAMA 2000;284:2886–2893.
17. Bernard DS, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol 2011;29:2821–2826.
18. Covinsky KE, Goldman L, Cook EF et al. The impact of serious illness on patients’ families. JAMA 1994;272:1839–1844.
19. Zafar SY, Peppercorn JM, Schrag D et al. The financial toxicity of cancer treatment: A pilot study assessingout-of-pocketexpensesandtheinsuredcancer patient’s experience. The Oncologist 2013;18:381–390.
20. Stump TK, Eghan N, Egleston BL et al. Cost concerns of patients with cancer. J Oncol Pract 2013; 9:251–257.
21. Ramsey S, BloughD,KirchhoffAetal.Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood) 2013;32:1143–1152.
22. Hershman DL, Shao T, Kushi LH et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 2011;126:529–537.
23. Neugut AI, Subar M, Wilde ET et al. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol 2011;29:2534–2542.
24. Nipp R, Zullig L, Peppercorn J et al. Coping with cancer treatment-related financial burden. J Clin Oncol 2014;32(suppl 31):161a.
25. Goldman DP, Berry SH, McCabe MS et al. Incremental treatment costs in national cancer institute-sponsored clinical trials. JAMA 2003;289: 2970–2977.
26. Zafar SY, Abernethy AP. Financial toxicity, part I: A new name for a growing problem. Oncology (Williston Park) 2013;27:80–81, 149.
27. Emanuel EJ, Schnipper LE, Kamin DY et al. The costs of conducting clinical research. J Clin Oncol 2003;21:4145–4150.
28. Goldman DP, Schoenbaum ML, Potosky AL et al. Measuring the incremental cost of clinical cancer research. J Clin Oncol 2001;19:105–110.
29. Martin PJ, Davenport-Ennis N, Petrelli NJ et al. Responsibility for costs associated with clinical trials. J Clin Oncol 2014;32:3357–3359.
30. Nipp RD, Powell E, Chabner Bet al. Recognizing the financial burden of cancer patients in clinical trials. The Oncologist 2015;20:572–575.
31. U.S. Department of Commerce. United States Census Bureau. http://factfinder.census.gov/faces/nav/jsf/pages/community_facts.xhtml. Accessed November 20, 2015.
32. CAHPS Clinician andGroup Surveys. Supplemental Items for the Adult Surveys. https://cahps.ahrq.gov/surveys-guidance/item-sets/2357a_Adult_Supp_Eng_2.pdf. Accessed September 20, 2015.
33. Miller SM, Hudson SV, Egleston BL et al. The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial. Psychooncology 2013;22:481–489.
34. Meropol NJ, Albrecht TL, Wong YN et al. Randomized trial of a web-based intervention to address barriers to clinical trials. J Clin Oncol 2013;31:6500a.
35. Manne S, Kashy D, Albrecht T et al. Knowledge, attitudes, and self-efficacy as predictors of preparedness for oncology clinical trials: Amediational model. Med Decis Making 2014;34:454–463.
36. Manne S, Kashy D, Albrecht T et al. Attitudinal barriers to participation in oncology clinical trials: Factor analysis and correlates of barriers. Eur J Cancer Care (Engl) 2015;24:28–38.
37. Fleisher L, Ruggieri DG, Miller SM et al. Application of best practice approaches for designing decision support tools: The preparatory education about clinical trials (PRE-ACT) study. Patient Educ Couns 2014;96:63–71.
38. Ellis PM, Butow PN, Tattersall MH. Informing breast cancer patients about clinical trials: A randomized clinical trial of an educational booklet. Ann Oncol 2002;13:1414–1423.
39. Du W, Mood D, Gadgeel S et al. An educational video to increase clinical trials enrollment among lung cancer patients. J Thorac Oncol 2008;3:23–29.
40. Du W, Mood D, Gadgeel S et al. An educational video to increase clinical trials enrollment among breast cancer patients. Breast Cancer Res Treat 2009;117:339–347.
41. Aaronson NK, Visser-Pol E, Leenhouts GH et al. Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. J Clin Oncol 1996;14:984–996.
42. McCaskill-Stevens W, McKinney MM, Whitman CG et al. Increasing minority participation in cancer clinical trials: The minority-based community clinical oncology program experience. J Clin Oncol 2005;23: 5247–5254.
43. Ford ME, Havstad SL, Davis SD. A randomized trial of recruitment methods for older African American men in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Clin Trials 2004;1:343–351.
44. Wieder R, Teal R, Saunders T et al. Establishing a minority-based community clinical oncology program: TheUniversityofMedicine andDentistryofNewJersey, New JerseyMedical School-University Hospital Cancer Center experience. J Oncol Pract 2013;9:e48–e54.
45. Advani AS, Atkeson B, Brown CL et al. Barriers to the participation of African-American patients with cancer in clinical trials: A pilot study. Cancer 2003;97:1499–1506.
46. Virani S, Burke L, Remick SC et al. Barriers to recruitment of rural patients in cancer clinical trials. J Oncol Pract 2011;7:172–177.
47. Somkin CP, Ackerson L, Husson G et al. Effect of medical oncologists’ attitudes on accrual to clinical trials in a community setting. J Oncol Pract 2013;9: e275–e283.
48. Kent EE, Forsythe LP, Yabroff KR et al. Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer 2013;119:3710–3717.
49. Banthin JS, Bernard DM. Changes in financial burdens for health care: National estimates for the population younger than 65 years, 1996 to 2003. JAMA 2006;296:2712–2719.
50. Shankaran V, Jolly S, Blough D et al. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: A population-based exploratory analysis. J Clin Oncol 2012;30:1608–1614.
51. Fenn KM, Evans SB, McCorkle R et al. Impact of financial burden of cancer on survivors’ quality of life. J Oncol Pract 2014;10:332–338.
52. Meropol NJ, Schulman KA. Cost of cancer care: Issues and implications. J Clin Oncol 2007;25:180–186.
53. Gerber DE, Lakoduk AM, Priddy LL et al. Temporal trends and predictors for cancer clinical trial availability for medically underserved populations. The Oncologist 2015;20:674–682.
54. Cutting Edge Information. Clinical Trials and Operations (PH192). http://www.cuttingedgeinfo.com/research/clinical-development/trial-operations/. Accessed September 20, 2015.